The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
No Access

Long-term psychiatric patients' knowledge about their medication

Published Online:https://doi.org/10.1176/ps.47.12.1385

Fifty-three long-term psychiatric outpatients at two clinics in Montreal were surveyed about their knowledge of the psychotropic medications they took and about their opinions of the quality of information they had received about medications. Most respondents were male and had a diagnosis of schizophrenia or schizoaffective disorder. Most respondents could identify one medication they took; nearly three- quarters could name a second one. Two-thirds reported having received information on medication, but many respondents wanted the information repeated, and more than half wanted more information. Chronicity and higher levels of education were associated with being better informed.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.